| | | 20,000+ Fresh Resumes Monthly | |
|
|
| |
Click here or scroll down to respond to this candidateCandidate's Name
Street Address cell PHONE NUMBER AVAILABLEKEY ATTRIBUTES:Oncology, Genomics, Precision Medicine, Business Development Solutions, Improving Workflows, Strategic Client Growth, Multi-President Club Award Winner, Leadership, Team-Player, Peer Development, CollaborationEXPERIENCE:SimBioSys, Inc (Consulting Agreement) February 2024 to August 2024Regional Sales DirectorRecent FDA clearance and Commercial Roll-Out of Software-based Precision Medicine platform TumorSight Viz converting 2D DCE MRI to interactive 3D representations. Provides Breast Surgeon additional resource and information for Surgical Planning and Clinical Decision Support. Future applications for Prone-to-Supine conversion, Neoadjuvant Response and Risk Assessment. Series B Funding denied resulting in RIF.Uncovered 11 new opportunities within first 3 months providing rapid strength to pipelineCreative strategy offered and implemented for Prone-to-Supine beta testingKey interaction with Executive Levels providing resource for budget and contract negotiationAgendia, Inc. February 2014 to August 2023Regional Director January 2018 to August 2023Covering multi-state region leading 7 Molecular Oncology Specialists and assisting in territory analysis, account strategies, effective targeting, and clinical knowledge advancement to achieve targeted company growth volumes. Continuous inspection of strategies, account trending, plan achievement, and skill advancement. Developed Key Regional KOL initiatives to leverage base business into broader bandwidth adoption.FY 2022 - #1 Region 103% to plan; Regional Director of the Year PRESIDENTS CLUBDeveloped and coached 2022 Rookie of the YearFY 2021 21% YoY GrowthDeveloped and coached 2021 Rookie of the Year; promoted another MOS to region trainerFY 2020 15% YoY GrowthDeveloped and coached 2020 Rookie of the YearSenior Molecular Oncology Specialist January 2017 to December 2017FY 2017 24% YOY Growth, Century ClubMolecular Oncology Specialist February 2014 to December 2016MammaPrint + BluePrint Genomic Assays for early-stage breast cancer. Covering Chicago area, Southern IL, and NW IN, targeting Medical Oncologists, Breast Surgeons and Pathologists. Targeted account strategy based on multi-discipline dynamics and nuances. Successful year-to-year growth and new account adoption.FY 2016 28% YOY Growth PRESIDENTS CLUB - ranked 2ndXoft, a subsidiary of iCAD February 2012 to January 2014Midwest Regional Business Development ManagerAccelerate the adoption of 50kv electronic brachytherapy radiation treatment technology for Breast IORT, 5 day APBI, skin/surface, and endometrial applications utilizing Xofts Axxent System. Call points include Breast Surgeons, Surgical Oncologists, Radiation Oncologists, Physicists, Dermatologists, and C-Level.Closed Rush Univ Med Center for IORT and Gyne applications, implementing as Center of ExcellenceExtensive presentations to multi-discipline teams and C-Level reviewing clinical details and ROI analysisInstigated IHN adoption process strategies, ie Wheaton Franciscan, McLaren, Aurora, Advocate, IU HealthNeurowave Medical Technologies, LLC November 2010 to January 2012Senior Sales ManagerVC-backed start-up, call points are Surgeons, Anesthesiologists, PACU/Recovery to drive transdermal neuromodulation device (Reletex) for relief and control of post-op nausea, Medical Oncologists (Nometex) for relief and control of chemotherapy-induced nausea, and OB/GYN (PrimaBella) for relief of pregnancy-induced nausea.Initiated 4 new Reletex accounts, generated largest revenue order to date 1st of 8 regionsSigned 6 new Nometex accounts for trial/evaluation program 1st of 5 regionsClosed 5 new accounts in September (4 PrimaBella, 1 Nometex), most in one month in company historyCalypso Medical June 2010 to August 2010Regional Sales ManagerVC-backed start-up. Target key Urology/Radiation Oncology referral practices to adopt GPS of the Body, real-time tracking technology managing prostate motion during radiation treatment. C-Level ROI results.Immediate interest turnaround implemented to free-standing center target with doctor/CLevel presentation.Integrated ground-level support through physicist group to start budgeting process for acquisition.Hologic (Cytyc Surgical Products) September 2005 to March 2010District Sales Manager April 2007 to March 2010Managed surgical and biopsy specialists (8-11 direct reports). Key Breast Surgeon and Radiation Oncology thought leader contacts and strategies. Detailed approach in developing goals, coaching, training, and measuring performance. Leadership role to the district by motivating, coaching, and influencing reps to revenue goal achievement. Integrated territory mapping goals during company merger transition and upsizing/downsizing.Ranked 1st of 7 Districts in Capital Revenue in 4/5 qtrs. Q109 through Q110122% to plan in MammoSite District sales Q209 2nd of 7 Districts$415,452 revenue growth in District Eviva Biopsy Sales FY09; 2nd of 7 Districts19% increase in District Celero Biopsy Sales FY08Developed 2 Circle of Excellence Award winners; promoted 2 team members to Senior Specialist RoleBreast Surgical Sales Specialist/Trainer September 2005 to March 2007Managed multiple call point consultative sale with strategic and tactical plans to Breast Surgeons and Radiation Oncologists selling the MammoSite Brachytherapy implantable balloon for early-stage breast cancer treatment.FY06 - $172,445 growth and 43% increase over 05Eight new Breast Surgeon office accounts 2nd of 7 specialistsKarl Storz Endoscopy America June 2004 to August 2005Lower Endoscopy Territory ManagerIncrease market share for Urology, Ob/Gyn, and General Surgery scope and instrumentation sets. Drive video and OR integration system conversions for above specialties. Comprehensive surgeon and sterile processing call points.FY05 YTD 133% to plan-video, 102% to plan urology, 103% to plan gyne, 112% to overall planFY04 68% increase in Laparoscopic instrumentsSanarus Medical, Inc. September 2002 to May 2004Territory Business ManagerVC-backed company driving Visica Cryoablation adoption for breast tumor treatment targeting breast surgeons for office-based procedure. Increased market share for Centrica Biopsy System to Radiologists and Breast Surgeons.FY 04 1st Qrt. 108% to plan on Visica procedures.FY 03 First TBM to have ten breast surgeons committed and treating patients with Visica.Conmed Corp. July 1995 to August 2002Surgical Systems Territory Manager/TrainerIncreased market share for E/S generators and disposables, Smoke Evac devices, Argon Beam Coag Systems, and Lap products. Extensive surgeon and gastroenterologist detailing, in-servicing, and follow-up.Coordinated and taught accredited CEU programs for OR nurses and techs:FY 01 - 1st VICE PRESIDENT PRESIDENTS CLUB 139% to quotaFY 00 - 191% to quota Ultraclean products #3 of 55; 312% to quota Laparoscopic products #2 of 55FY 99 - PRESIDENTS CLUB 104% to overall quotaFY 98 - 2nd VICE PRESIDENT PRESIDENTS CLUB 117% to quotaFY 97 - 109% to quota Electrosurgical generatorsFY 96 - PRESIDENTS CLUB 104% to overall quotaEDUCATION: BBA Marketing, The University of IowaCOURSES: Brennan Institute, Accordance Negotiation Skills, Leading for Impact, Leadership Essentials |
